Minnesota's Solventum sells purification business to Thermo Fisher for $4.1 billion
M health care spinoff Solventum is selling its purification business to Thermo Fisher Scientific for $4.1 billion in cash to pay down its billions in outstanding debt. Solventum CEO Bryan Hanson said in a news release that the sale,
Solventum surpassed fourth-quarter revenue and earnings expectations while facing challenges in segments and regulatory ...
Thermo Fisher Scientific is expanding its life sciences portfolio by acquiring a division of Solventum that provides technologies and products used in the manufacturing of biologic drugs.
--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE ... that the company has entered into a definitive agreement with Solventum (NYSE: SOLV) to acquire Solventum’s Purification & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback